News | April 01, 2025
Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
AstraZeneca Pharma India discontinues manufacturing of Imdur
Positions Curium as leading manufacturer of Lu-177 isotope
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Subscribe To Our Newsletter & Stay Updated
